142 related articles for article (PubMed ID: 33495063)
1. Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs.
Andrasina T; Juracek J; Zavadil J; Cechova B; Rohan T; Vesela P; Paldor M; Slaby O; Goldberg SN
J Vasc Interv Radiol; 2021 Mar; 32(3):403-411. PubMed ID: 33495063
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Changes in Circulating MicroRNA Levels in Liver Cancer Patients Undergoing Thermal Ablation and Transarterial Chemoembolization.
Zavadil J; Juráček J; Čechová B; Andrašina T; Slabý O; Goldberg N
Klin Onkol; 2019; 32(Supplementum1):164-166. PubMed ID: 31064190
[TBL] [Abstract][Full Text] [Related]
3. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.
Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y
PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study.
Sheta E; El-Kalla F; El-Gharib M; Kobtan A; Elhendawy M; Abd-Elsalam S; Mansour L; Amer I
Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1198-203. PubMed ID: 27362551
[TBL] [Abstract][Full Text] [Related]
5. Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.
Liu D; Liu M; Su L; Wang Y; Zhang X; Long H; Kuang M; Xie X; Lin M
J Vasc Interv Radiol; 2019 Dec; 30(12):1879-1886. PubMed ID: 31669087
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Zhan M; Li Y; Hu B; He X; Huang J; Zhao Y; Fu S; Lu L
J Vasc Interv Radiol; 2014 Aug; 25(8):1279-1287.e1. PubMed ID: 24935355
[TBL] [Abstract][Full Text] [Related]
7. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH
J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146
[TBL] [Abstract][Full Text] [Related]
8. Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
Kim SS; Nam JS; Cho HJ; Won JH; Kim JW; Ji JH; Yang MJ; Park JH; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
J Gastroenterol Hepatol; 2017 Jan; 32(1):199-207. PubMed ID: 27194671
[TBL] [Abstract][Full Text] [Related]
9. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
Zheng L; Li HL; Guo CY; Luo SX
Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181
[TBL] [Abstract][Full Text] [Related]
11. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
12. Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study.
Abdelaziz AO; Abdelhalim H; Elsharkawy A; Shousha HI; Abdelmaksoud AH; Soliman ZA; Seif MI; Sayed DB; Farouk MH; Elbaz TM; Nabeel MM
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):685-691. PubMed ID: 30640743
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma.
Li Z; Jiao D; Han X; Si G; Li Y; Liu J; Xu Y; Zheng B; Zhang X
Cancer Imaging; 2020 Jan; 20(1):13. PubMed ID: 32000862
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma.
Yuan W; Yang MJ; Xu J; Yan ZP; Liu R; Qu XD; Wang JH; Qian S
Technol Cancer Res Treat; 2018 Jan; 17():1533033818788529. PubMed ID: 30045673
[TBL] [Abstract][Full Text] [Related]
15. Circulating MiRNA-373 as a Predictor of Response to Super-selective Transarterial Chemoembolization Bridging Therapy in Hepatocellular Carcinoma Patients Awaiting Liver Transplantation.
Tork ASE; Kamel AAF; Zaki MA; Abo El-Wafa RAH; El-Assar OS; Ibrahim Abdelkarem OA
Asian Pac J Cancer Prev; 2023 Jan; 24(1):291-299. PubMed ID: 36708579
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
17. Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization.
Ali HEA; Emam AA; Zeeneldin AA; Srour R; Tabashy R; El-Desouky ED; Abd Elmageed ZY; Abdel-Wahab AA
Clin Biochem; 2019 Mar; 65():45-52. PubMed ID: 30653948
[TBL] [Abstract][Full Text] [Related]
18. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis.
Abdelaziz AO; Nabeel MM; Elbaz TM; Shousha HI; Hassan EM; Mahmoud SH; Rashed NA; Ibrahim MM; Abdelmaksoud AH
Scand J Gastroenterol; 2015 Apr; 50(4):479-84. PubMed ID: 25592058
[TBL] [Abstract][Full Text] [Related]
19. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
20. Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma.
Vogl TJ; Riegelbauer LJ; Oppermann E; Kostantin M; Ackermann H; Trzmiel A; Stein S; Eichler K; Zharov VP; Roy D; Schnitzbauer AA; Strücker B; Pascher A; Bechstein WO; Juratli MA
PLoS One; 2021; 16(2):e0246527. PubMed ID: 33577574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
